Peter Rahmer - 28 Apr 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Chief Corporate Development Officer
Signature
/s/ Brian Adams, as Attorney-in-Fact
Issuer symbol
RLAY
Transactions as of
28 Apr 2025
Net transactions value
-$36,541
Form type
4
Filing time
30 Apr 2025, 20:25:38 UTC
Previous filing
31 Mar 2025
Next filing
01 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale $4,324 -1,364 -0.34% $3.17 400,820 28 Apr 2025 Direct F1, F2
transaction RLAY Common Stock Sale $32,217 -10,739 -2.7% $3.00 390,081 30 Apr 2025 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,505 shares of restricted stock units ("RSUs") on April 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 247,107 shares underlying RSUs.
F3 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,392 shares of RSUs on April 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F4 Includes 204,715 shares underlying RSUs.

Remarks:

Chief Corporate Development Officer